Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II: Treatment of Adenovirus and Cytomegalovirus Infection Post Human Allogeneic Stem Cell Transplantation With Short-term Expanded Virus-specific T Cells

NCT02702427 is registered in ClinicalTrials.gov with St. Anna Kinderkrebsforschung as lead sponsor.

NCT NCT02702427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02702427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II: Treatment of Adenovirus and Cytomegalovirus Infection Post Human Allogeneic Stem Cell Transplantation With Short-term Expanded Virus-specific T Cells
Lead sponsor
St. Anna Kinderkrebsforschung
Phase
Phase 1/2
Overall status
Withdrawn
Start date
August 3, 2016
Completion date
April 1, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenovirus infection, cytomegalovirus infection